New Immunotherapy Shows Promise in Fighting Colon Cancer

NIH researchers achieve tumor shrinkage with new immunotherapy using engineered cells.

CI Photos/Shutterstock

In a new development, scientists have weaponized patients’ own immune cells to combat metastatic colon cancer.

This innovative approach, which genetically enhances lymphocytes to target and destroy cancer cells, has shown promising results in a recent National Institutes of Health trial.